JPMorgan Chase & Co’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Sell |
12,337
-4,628
| -27% | -$9.77K | ﹤0.01% | 5272 |
|
|
2025
Q1 | $20.7K | Sell |
16,965
-42,728
| -72% | -$52.1K | ﹤0.01% | 5275 |
|
|
2024
Q4 | $77K | Buy |
59,693
+29,065
| +95% | +$37.5K | ﹤0.01% | 4865 |
|
|
2024
Q3 | $84.2K | Buy |
30,628
+18,907
| +161% | +$52K | ﹤0.01% | 4789 |
|
|
2024
Q2 | $26.5K | Buy |
11,721
+9,850
| +526% | +$22.3K | ﹤0.01% | 5088 |
|
|
2024
Q1 | $4.47K | Buy |
1,871
+48
| +3% | +$115 | ﹤0.01% | 5465 |
|
|
2023
Q4 | $3.03K | Buy |
1,823
+1,730
| +1,860% | +$2.87K | ﹤0.01% | 5619 |
|
|
2023
Q3 | $179 | Buy |
93
+50
| +116% | +$96 | ﹤0.01% | 5890 |
|
|
2023
Q2 | $62 | Hold |
43
| – | – | ﹤0.01% | 5824 |
|
|
2023
Q1 | $0 | Hold |
43
| – | – | ﹤0.01% | 5916 |
|
|
2022
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 5703 |
|
|
2022
Q3 | $0 | Hold |
43
| – | – | ﹤0.01% | 5621 |
|
|
2022
Q2 | $0 | Hold |
43
| – | – | ﹤0.01% | 5701 |
|
|
2022
Q1 | $0 | Hold |
43
| – | – | ﹤0.01% | 5804 |
|
|
2021
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 5772 |
|
|
2021
Q3 | $0 | Hold |
43
| – | – | ﹤0.01% | 5605 |
|
|
2021
Q2 | $0 | Sell |
43
-100,512
| -100% | – | ﹤0.01% | 5525 |
|
|
2021
Q1 | $218K | Sell |
100,555
-3,158
| -3% | -$6.85K | ﹤0.01% | 4421 |
|
|
2020
Q4 | $232K | Buy |
103,713
+82,039
| +379% | +$184K | ﹤0.01% | 4105 |
|
|
2020
Q3 | $72K | Sell |
21,674
-6,337
| -23% | -$21.1K | ﹤0.01% | 4180 |
|
|
2020
Q2 | $85K | Sell |
28,011
-12,588
| -31% | -$38.2K | ﹤0.01% | 4022 |
|
|
2020
Q1 | $79K | Buy |
40,599
+27,467
| +209% | +$53.4K | ﹤0.01% | 4010 |
|
|
2019
Q4 | $38K | Hold |
13,132
| – | – | ﹤0.01% | 4308 |
|
|
2019
Q3 | $48K | Buy |
13,132
+2,996
| +30% | +$11K | ﹤0.01% | 4271 |
|
|
2019
Q2 | $41K | Sell |
10,136
-178,555
| -95% | -$722K | ﹤0.01% | 4331 |
|
|
2019
Q1 | $964K | Buy |
+188,691
| New | +$964K | ﹤0.01% | 3045 |
|
|
2014
Q2 | – | Sell |
-10,745
| Closed | -$165K | – | 3449 |
|
|
2014
Q1 | $165K | Buy |
+10,745
| New | +$165K | ﹤0.01% | 3363 |
|